Dozee to Launch AI-based ECG Patch for Remote Cardiac Monitoring

Dozee, India’s first contactless Remote Patient Monitoring (RPM) company will soon launch an ambulatory Electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD).

This easy-to-use ECG patch augments Dozee’s current AI-powered RPM system to play a key role in assisting Health Care Professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety.

This ambulatory ECG patch monitors the electrical activity of your heart continuously over multiple days. It will help detect critical cardiac arrhythmias, so HCPs can manage critical situations with swift data-backed medical decisions. Since, Dozee also allows them to remotely monitor vital parameters such as heart rate, respiration rate, blood pressure, oxygen saturation, and temperature, HCPs can get a comprehensive understanding of the patient’s condition.

The ECG patch is small, flexible, light and convenient to use and the physician can remotely get alerts and view the live and continuous ECG of the patient from anywhere as the system is cloud-enabled.

Dr. Ruchit Shah, Interventional Cardiologist, Saifee Hospital, Mumbai said…

“The only way we can diagnose patients at an increased risk of sudden cardiac arrest and death or cardiovascular disorders is by early detection. But, with a large gap in the number of healthcare facilities and people in need of care, these signs can often be missed by conventional testing methods and can be bridged by integrating with technology – and Dozee’s ECG patch helps us do just that. Patients who are at risk of suffering from a cardiovascular incident tend to show some signal intensity changes on ECG which can be picked up by continuous remote monitoring. These changes, when picked up early and detected can be treated on time and can be lifesaving. Dozee’s ECG patch is a small step in early detection and treatment and can help in improving longevity, lifestyle and reduction in mortality.”

“We are excited to enter the cardiac monitoring segment in India with our ECG patch, which is an addition to our vitals monitoring portfolio. This technology can be especially pivotal in India, as cardiovascular disease has become the leading cause of morbidity and mortality over the last three decades. We envisage that Dozee’s Remote Patient Monitoring (RPM) portfolio will become an integral part of cardiac care in the near future both in hospital and at home,” said Mudit Dandwate, CEO & Co-founder – Dozee

With an estimated prevalence range from 1.3 million to 4.6 million cardiac cases a year, and an annual incidence of 4.91k–1.8 million [1], cardiac ailments are a fast growing disease burden. While there are efforts being made to contain the epidemic by educating people about preventive measures, especially those at higher risk, the ever increasing burden of patients living with life threatening indications of the ailment, poses a noteworthy challenge.

Dozee’s new foray into cardiology will help take patient safety to the next level and change the way patients are monitored in the hospital – ensuring support across the spectrum of public and private healthcare.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version